You are here

Cellecta, Incorporated

Company Information
Address
320 Logue Ave
Mountain View, CA 94043-4040
United States


http://www.cellecta.com

Information

UEI: ENT1Z37DAHJ8

# of Employees: 18


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. CRISPR Genome-Wide sgRNA Library Screening Platform

    Amount: $1,496,262.00

    Open Resource CRISPR CASGenome Wide sgRNA Library Screening PlatformABSTRACTCRISPR technology made its giant leap from bacteria to mammalian system when a few landmark discoveries that demonstrated Ca ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Open Resource CRISPR/CAS9 Genome-Wide sgRNA Library Screening Platform

    Amount: $224,905.00

    DESCRIPTION provided by applicant Despite of rapid advances in elucidating the molecular basis of human diseases an ostensibly more difficult post genomic challenge is the functional annotation of ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  3. TOPIC 316 PHASE I: GENETIC ANALYSIS OF CTCS AT THE SINGLE CELL LEVEL; HHSN261201

    Amount: $299,952.00

    Not Available

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  4. IGF::OT::IGF SBIR PHASE II TOPIC 290 RNAI SYNTHETIC LETHAL SCREEN IN CANCER CELL MODELS.

    Amount: $999,596.00

    The DNA Damage and Repair (DDR) signaling modules are among the most commonly deregulated genes in human tumors. Deficiencies in DDR pathways are believed to influence tumorigenic processes by promo ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  5. Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta

    Amount: $1,865,575.00

    DESCRIPTION (provided by applicant): Targeted therapies have the ability to specifically interact with and block proliferation of cancer cells by interfering with targeted gene products required for ...

    SBIRPhase II2011Department of Health and Human Services National Institutes of Health
  6. Not Available

    Amount: $199,681.00

    Despite rapid advances in elucidating the molecular basis of human diseases, an ostensibly more difficult post-genomic challenge is the functional annotation of disease-specific signaling pathways and ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  7. Functionally Validated Lentiviral siRNA libraries

    Amount: $1,860,300.00

    DESCRIPTION (provided by applicant): Despite rapid advances in elucidating the molecular basis of human diseases, an ostensibly more difficult post-genomic challenge is the functional annotation of di ...

    SBIRPhase II2010Department of Health and Human Services National Institutes of Health
  8. Isolation of Peptide Radioprotectors

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Systemic exposure to ionizing radiation (IR) results in cell damage in radiosensitive tissues. It is therefore highly desirable to develop efficient radioprotectiv ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  9. Identification of Hematopoietic Stem and Progenitor Cell Viability Genes

    Amount: $249,465.00

    DESCRIPTION (provided by applicant): More than 15,000 allogeneic and 30,000 autologous hematopoietic stem cell transplantations (HSCT) are performed annually worldwide (1). Approximately 40% of patien ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  10. Drug Targets of Heat Shock Response

    Amount: $237,368.00

    DESCRIPTION (provided by applicant): The heat shock response (HSR) induced by cell stress is a common protection mechanism elicited in a wide range of tumors. This response is closely associated with ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government